ClinConnect ClinConnect Logo
Search / Trial NCT06926725

Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients

Launched by MAHMOUD AWAD RAMADAN ELKHOLY · Apr 11, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how two treatments—high intensity interval training (a type of exercise) and ultrasound cavitation (a non-invasive procedure that uses sound waves)—can help improve cholesterol and fat levels in patients with type 2 diabetes who have excess belly fat. The goal is to see if combining these two approaches can lead to better health outcomes for people facing this condition.

To be eligible for the study, participants should be adults with type 2 diabetes and a waist measurement over 102 cm for men or over 88 cm for women. They should also have cholesterol levels that are borderline to high risk. However, people with certain health issues like kidney, heart, or lung diseases, as well as those who are pregnant or breastfeeding, won't be able to participate. If you join the trial, you can expect to engage in the exercise and ultrasound treatments while being monitored by the research team to see how your health improves. The study is not yet recruiting participants, but it's an exciting opportunity for those who qualify to help advance our understanding of managing diabetes through lifestyle changes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patient with type 2 diabetes.
  • waist circumference \>102 cm in male ,\>88 cm in female
  • lipid profile range will be (between border line and high risk ).
  • Exclusion criteria:
  • Kidney disease Heart disease Lung disease ,Liver disease ,Neurological disorders ,Pregnant women , breast feeding, immune deficiency , cancer Heavy smoker
  • Exclusion Criteria:
  • -

About Mahmoud Awad Ramadan Elkholy

Mahmoud Awad Ramadan Elkholy is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic approaches, the organization specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a team of experienced professionals and state-of-the-art methodologies, Mahmoud Awad Ramadan Elkholy ensures adherence to regulatory standards and ethical guidelines, fostering collaborations with healthcare institutions and stakeholders to drive the development of effective treatments. Their mission is to contribute to the scientific community by facilitating robust clinical evidence that informs healthcare practices.

Locations

Giza, Cairo, Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported